NHS nod for cost-cut leukaemia drug

Roche has agreed a discount on obinutuzumab that has led Nice to recommend it is made available on the NHS A life-prolonging leukaemia drug rejected by the health advisory body is to be made available on the NHS after the manufacturer agreed to lower the price. The...